{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:52:55Z","timestamp":1792065175502,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":270,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NAM Journal"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.namjnl.2026.100139","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:19:39Z","timestamp":1790810379000},"page":"100139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Assessing in vitro long-term liver metabolism models to characterize intrinsic clearance determination in NGRAs"],"prefix":"10.1016","volume":"2","author":[{"given":"Jaqueline","family":"Meinhardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-9830","authenticated-orcid":false,"given":"Abdulkarim","family":"Najjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1045-0748","authenticated-orcid":false,"given":"Nicola J.","family":"Hewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5258-3605","authenticated-orcid":false,"given":"Andreas","family":"Schepky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.namjnl.2026.100139_bib0001","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1124\/dmd.120.000013","article-title":"Simplifying the execution of HepatoPac MetID experiments: metabolite profile and intrinsic clearance comparisons","volume":"48","author":"Ballard","year":"2020","journal-title":"Drug. Metab. Dispos."},{"issue":"1","key":"10.1016\/j.namjnl.2026.100139_bib0002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2174\/138920007779315053","article-title":"Scaling factors for the extrapolation of in vivo metabolic drug clearance from in vitro data: reaching a consensus on values of human microsomal protein and hepatocellularity per gram of liver","volume":"8","author":"Barter","year":"2007","journal-title":"Curr. Drug. Metab."},{"key":"10.1016\/j.namjnl.2026.100139_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2021.152819","article-title":"Evaluation and comparison of in vitro intrinsic clearance rates measured using cryopreserved hepatocytes from humans, rats, and rainbow trout","volume":"457","author":"Black","year":"2021","journal-title":"Toxicology"},{"issue":"4","key":"10.1016\/j.namjnl.2026.100139_bib0004","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1124\/dmd.115.067769","article-title":"Determination of human hepatocyte intrinsic clearance for slowly metabolized compounds: comparison of a primary hepatocyte\/stromal cell co-culture with plated primary hepatocytes and HepaRG","volume":"44","author":"Bonn","year":"2016","journal-title":"Drug. Metab. Dispos."},{"issue":"2","key":"10.1016\/j.namjnl.2026.100139_bib0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1124\/dmd.106.011569","article-title":"Evaluation of cryopreserved human hepatocytes as an alternative in vitro system to microsomes for the prediction of metabolic clearance","volume":"35","author":"Brown","year":"2007","journal-title":"Drug. Metab. Dispos."},{"issue":"4","key":"10.1016\/j.namjnl.2026.100139_bib0006","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/074823379701300401","article-title":"Physiological parameter values for physiologically based pharmacokinetic models","volume":"13","author":"Brown","year":"1997","journal-title":"Toxicol. Ind. Health"},{"issue":"4","key":"10.1016\/j.namjnl.2026.100139_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100051","article-title":"Improved clearance predictions for aldehyde oxidase substrates using a novel triculture human hepatocyte model","volume":"53","author":"Byer-Alcorace","year":"2025","journal-title":"Drug. Metab. Dispos."},{"issue":"2","key":"10.1016\/j.namjnl.2026.100139_bib0008","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/187231207780363660","article-title":"An estimate of the number of hepatocyte donors required to provide reasonable estimates of human hepatic clearance from in vitro experiments","volume":"1","author":"Byers","year":"2007","journal-title":"Drug. Metab. Lett."},{"issue":"12","key":"10.1016\/j.namjnl.2026.100139_bib0009","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1080\/00498254.2017.1395927","article-title":"Qualitative and quantitative prediction of human in vivo metabolic pathways in a human hepatocyte-murine stromal cell co-culture model","volume":"48","author":"Cassidy","year":"2018","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.namjnl.2026.100139_bib0010","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1124\/dmd.113.053397fullarticlecorrection","article-title":"Meeting the challenge of predicting hepatic clearance of compounds slowly metabolized by cytochrome P450 using a novel hepatocyte model, HepatoPac","volume":"47","author":"Chan","year":"2019","journal-title":"Drug. Metab. Dispos."},{"issue":"6","key":"10.1016\/j.namjnl.2026.100139_bib0011","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bcp.2009.05.013","article-title":"Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human","volume":"78","author":"Chao","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.namjnl.2026.100139_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","volume":"2010","author":"Chateauvieux","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"8","key":"10.1016\/j.namjnl.2026.100139_bib0013","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1089\/ten.tec.2013.0562","article-title":"Development of 3D dynamic flow model of human liver and its application to prediction of metabolic clearance of 7-ethoxycoumarin","volume":"20","author":"Choi","year":"2014","journal-title":"Tissue Eng. C. Methods"},{"issue":"7","key":"10.1016\/j.namjnl.2026.100139_bib0014","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.namjnl.2026.100139_bib0015","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/2472555219831407","article-title":"Application of new cellular and microphysiological systems to drug metabolism optimization and their positioning respective to in silico tools","volume":"24","author":"Docci","year":"2019","journal-title":"Slas Discov."},{"key":"10.1016\/j.namjnl.2026.100139_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1345992","article-title":"Next generation risk assessment: an ab initio case study to assess the systemic safety of the cosmetic ingredient, benzyl salicylate, after dermal exposure","volume":"15","author":"Ebmeyer","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.namjnl.2026.100139_bib0017","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1021\/mp300476z","article-title":"Application of in silico, in vitro and preclinical pharmacokinetic data for the effective and efficient prediction of human pharmacokinetics","volume":"10","author":"Grime","year":"2013","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.namjnl.2026.100139_bib0018","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s004410100429","article-title":"Regulation of cell morphology and cytochrome P450 expression in human hepatocytes by extracellular matrix and cell-cell interactions","volume":"306","author":"Hamilton","year":"2001","journal-title":"Cell. Tissue Res."},{"issue":"1","key":"10.1016\/j.namjnl.2026.100139_bib0019","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/03602530601093489","article-title":"Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies","volume":"39","author":"Hewitt","year":"2007","journal-title":"Drug. Metab. Rev."},{"issue":"8","key":"10.1016\/j.namjnl.2026.100139_bib0020","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1021\/acs.molpharmaceut.6b00396","article-title":"Use of H\u03bcREL human coculture system for prediction of intrinsic clearance and metabolite formation for slowly metabolized compounds","volume":"13","author":"Hultman","year":"2016","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.namjnl.2026.100139_bib0021","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1124\/dmd.115.066431","article-title":"Low-turnover drug molecules: a current challenge for drug metabolism scientists","volume":"43","author":"Hutzler","year":"2015","journal-title":"Drug. Metab. Dispos."},{"issue":"9","key":"10.1016\/j.namjnl.2026.100139_bib0022","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/dmd.104.000125","article-title":"Substrate depletion approach for determining in vitro metabolic clearance: time dependencies in hepatocyte and microsomal incubations","volume":"32","author":"Jones","year":"2004","journal-title":"Drug. Metab. Dispos."},{"issue":"1","key":"10.1016\/j.namjnl.2026.100139_bib0023","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nbt1361","article-title":"Microscale culture of human liver cells for drug development","volume":"26","author":"Khetani","year":"2008","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.namjnl.2026.100139_bib0024","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1208\/s12248-016-0019-7","article-title":"Metabolic profiling of human long-term liver models and hepatic clearance predictions from in vitro data using nonlinear mixed-effects modeling","volume":"19","author":"Kratochwil","year":"2017","journal-title":"Aaps J."},{"issue":"8","key":"10.1016\/j.namjnl.2026.100139_bib0025","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1124\/dmd.118.081596","article-title":"Development and characterization of a human hepatocyte low intrinsic clearance assay for use in drug discovery","volume":"46","author":"Lancett","year":"2018","journal-title":"Drug. Metab. Dispos."},{"issue":"12","key":"10.1016\/j.namjnl.2026.100139_bib0026","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1124\/dmd.30.12.1446","article-title":"Development of a novel in vitro model to predict hepatic clearance using fresh, cryopreserved, and sandwich-cultured hepatocytes","volume":"30","author":"Lau","year":"2002","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.namjnl.2026.100139_bib0027","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1749-6632.2009.05113.x","article-title":"Epilepsy in the elderly","volume":"1184","author":"Leppik","year":"2010","journal-title":"Ann. N Acad. Sci."},{"issue":"1","key":"10.1016\/j.namjnl.2026.100139_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfad081","article-title":"ADME characterization and PBK model development of 3 highly protein-bound UV filters through topical application","volume":"196","author":"Li","year":"2023","journal-title":"Toxicol. Sci."},{"issue":"5","key":"10.1016\/j.namjnl.2026.100139_bib0029","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00204-003-0440-4","article-title":"Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism","volume":"77","author":"Ligocka","year":"2003","journal-title":"Arch. Toxicol."},{"issue":"14","key":"10.1016\/j.namjnl.2026.100139_bib0030","first-page":"17","article-title":"Micropatterned co-cultures of human hepatocytes and stromal cells for the assessment of drug clearance and drug-drug interactions","volume":"72","author":"Lin","year":"2017","journal-title":"Curr. Protoc. Toxicol."},{"key":"10.1016\/j.namjnl.2026.100139_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.104722","article-title":"Towards harmonization of test methods for in vitro hepatic clearance studies","volume":"63","author":"Louisse","year":"2020","journal-title":"Toxicol. Vitro"},{"issue":"9","key":"10.1016\/j.namjnl.2026.100139_bib0032","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s002280050684","article-title":"Experimental, extrapolated and truncated areas under the concentration-time curve in bioequivalence trials","volume":"55","author":"Marzo","year":"1999","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.namjnl.2026.100139_bib0033","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1124\/dmd.104.000026","article-title":"Evaluation of fresh and cryopreserved hepatocytes as in vitro drug metabolism tools for the prediction of metabolic clearance","volume":"32","author":"McGinnity","year":"2004","journal-title":"Drug. Metab. Dispos."},{"issue":"7","key":"10.1016\/j.namjnl.2026.100139_bib0034","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00204-024-03749-8","article-title":"In vitro to in vivo extrapolation to derive a metabolism factor for estimating the aggregate exposure to salicylic acid after dermal exposure of its esters","volume":"98","author":"Najjar","year":"2024","journal-title":"Arch. Toxicol."},{"issue":"12","key":"10.1016\/j.namjnl.2026.100139_bib0035","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1007\/s00204-022-03356-5","article-title":"Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment","volume":"96","author":"Najjar","year":"2022","journal-title":"Arch. Toxicol."},{"issue":"7","key":"10.1016\/j.namjnl.2026.100139_bib0036","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.bcp.2009.11.010","article-title":"A microfluidic hepatic coculture platform for cell-based drug metabolism studies","volume":"79","author":"Novik","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.namjnl.2026.100139_bib0037","doi-asserted-by":"crossref","first-page":"6772","DOI":"10.1038\/s41598-024-57463-7","article-title":"Characterization of diseased primary human hepatocytes in an all-human cell-based triculture system","volume":"14","author":"Odanga","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.namjnl.2026.100139_bib0038","article-title":"An all-human hepatic culture system for drug development applications","volume":"200","author":"Odanga","year":"2023","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.namjnl.2026.100139_bib0039","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejps.2009.12.007","article-title":"Prediction of the in vitro intrinsic clearance determined in suspensions of human hepatocytes by using artificial neural networks","volume":"39","author":"Paixao","year":"2010","journal-title":"Eur. J. Pharm. Sci: Off. J. Eur. Fed. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.namjnl.2026.100139_bib0040","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/dmd.123.001638","article-title":"Comparison of human long-term liver models for clearance prediction of slowly metabolized compounds","volume":"52","author":"Preiss","year":"2024","journal-title":"Drug. Metab. Dispos."},{"issue":"1","key":"10.1016\/j.namjnl.2026.100139_bib0041","first-page":"113","article-title":"Building confidence in PBK model predictions in the absence of human kinetic data: Benzophenone-4 case study","volume":"43","author":"Punt","year":"2026","journal-title":"Altex"},{"issue":"4","key":"10.1016\/j.namjnl.2026.100139_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmd.2025.100052","article-title":"Quantitative clinical risk assessment of CYP2C, UDP-glucuronosyltransferase, P-glycoprotein induction, and complex drug-drug interactions using TruVivo human hepatocyte triculture platform","volume":"53","author":"Ramsden","year":"2025","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.namjnl.2026.100139_bib0043","series-title":"(Scientific Committee on Consumer Safety), Opinion on N-methyl-2-pyrrolidone (NMP)","year":"2011"},{"key":"10.1016\/j.namjnl.2026.100139_bib0044","series-title":"Opinion on Benzyl Salicylate (CAS No. 118-58-1, EC No. 204-262-9), Preliminary Version of 6-7 June 2023, 37 SCCS\/1656\/23","year":"2023"},{"key":"10.1016\/j.namjnl.2026.100139_bib0045","first-page":"12","article-title":"Optimization of extracellular matrix for primary human hepatocyte cultures using mixed collagen-Matrigel matrices","volume":"22","author":"Seidemann","year":"2023","journal-title":"Excli J."},{"issue":"10","key":"10.1016\/j.namjnl.2026.100139_bib0046","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1002\/jps.23262","article-title":"A comprehensive evaluation of metabolic activity and intrinsic clearance in suspensions and monolayer cultures of cryopreserved primary human hepatocytes","volume":"101","author":"Smith","year":"2012","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.namjnl.2026.100139_bib0047","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1124\/mol.66.4.1004","article-title":"Modulation of multidrug resistance-associated protein 2 (Mrp2) and Mrp3 expression and function with small interfering RNA in sandwich-cultured rat hepatocytes","volume":"66","author":"Tian","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"8","key":"10.1016\/j.namjnl.2026.100139_bib0048","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/j.xphs.2023.03.001","article-title":"Evaluation of a five-probe metabolic control cocktail in long-term cocultured human hepatocytes","volume":"112","author":"Tynelius","year":"2023","journal-title":"J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.namjnl.2026.100139_bib0049","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1007\/s11095-015-1749-4","article-title":"Predicting clearance mechanism in drug discovery: extended clearance classification system (ECCS)","volume":"32","author":"Varma","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.namjnl.2026.100139_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105504","article-title":"The morphology, functionality, and longevity of a novel all human hepatic cell-based tri-culture system","volume":"86","author":"Weaver","year":"2023","journal-title":"Toxicol. Vitro"}],"container-title":["NAM Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050620426000643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S3050620426000643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:08:22Z","timestamp":1792062502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S3050620426000643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":50,"alternative-id":["S3050620426000643"],"URL":"https:\/\/doi.org\/10.1016\/j.namjnl.2026.100139","relation":{},"ISSN":["3050-6204"],"issn-type":[{"value":"3050-6204","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing in vitro long-term liver metabolism models to characterize intrinsic clearance determination in NGRAs","name":"articletitle","label":"Article Title"},{"value":"NAM Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.namjnl.2026.100139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100139"}}